Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Medicina (Kaunas, Lithuania)
|
August 28, 2025
Comparison of Total Antioxidant Capacity in COPD, Asthma, and Asthma-COPD Overlap Patients
Melike Yüksel Yavuz, Muzaffer Onur Turan, Hayat Özkanay, et al.
African Health Sciences
|
January 15, 2024
Frequency of latent tuberculosis in patients receiving Anti-TNF-Alpha therapy
İpek Coşkunol, Onur Turan, Aysegul Baysak, et al.
Expert Review of Respiratory Medicine
|
May 4, 2021
Clinical characteristics and outcomes of hospitalized COVID-19 patients with COPD
Onur Turan, Burcu Arpınar Yigitbas, Pakize Ayşe Turan, et al.
Tuberkuloz Ve Toraks
|
July 20, 2014
[Smoking related behaviours in Izmir]
Pakize Ayşe Turan, Gül Ergor, Onur Turan, et al.
Tuberkuloz Ve Toraks
|
April 15, 2021
Pneumomediastinum as a complication of COVID-19 disease: A case report
Betül İkbal Doğan, Ceyda Mahleç Anar, Bünyamin Sertoğullarından, et al.
Kulak Burun Bogaz Ihtisas Dergisi : KBB = Journal of Ear, Nose, and Throat
|
July 19, 2002
[The incidence of Usher's syndrome and its clinical types]
Müslüm Bereketoğlu, Emel Uçak Avşar, Onur Turan, et al.
Tuberkuloz Ve Toraks
|
May 13, 2014
[The changes in smoking related behaviours and second hand smoke after the smoking ban in Izmir]
Pakize Ayşe Turan, Gül Ergör, Onur Turan, et al.
The Clinical Respiratory Journal
|
December 2, 2011
Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT)
Onur Turan, Ozhan Ozdogan, Duygu Gurel, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University
|
August 10, 2017
The contribution of clinical assessments to the diagnostic algorithm of pulmonary embolism
Onur Turan, Deniz Turgut, Turkan Gunay, et al.
European Journal of Clinical Pharmacology
|
February 24, 2024
Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?
Onur Turan, Nalan Ogan, Fulsen Bozkus, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Medicina (Kaunas, Lithuania)
|
August 28, 2025
Comparison of Total Antioxidant Capacity in COPD, Asthma, and Asthma-COPD Overlap Patients
Melike Yüksel Yavuz, Muzaffer Onur Turan, Hayat Özkanay, et al.
African Health Sciences
|
January 15, 2024
Frequency of latent tuberculosis in patients receiving Anti-TNF-Alpha therapy
İpek Coşkunol, Onur Turan, Aysegul Baysak, et al.
Expert Review of Respiratory Medicine
|
May 4, 2021
Clinical characteristics and outcomes of hospitalized COVID-19 patients with COPD
Onur Turan, Burcu Arpınar Yigitbas, Pakize Ayşe Turan, et al.
Tuberkuloz Ve Toraks
|
July 20, 2014
[Smoking related behaviours in Izmir]
Pakize Ayşe Turan, Gül Ergor, Onur Turan, et al.
Tuberkuloz Ve Toraks
|
April 15, 2021
Pneumomediastinum as a complication of COVID-19 disease: A case report
Betül İkbal Doğan, Ceyda Mahleç Anar, Bünyamin Sertoğullarından, et al.
Kulak Burun Bogaz Ihtisas Dergisi : KBB = Journal of Ear, Nose, and Throat
|
July 19, 2002
[The incidence of Usher's syndrome and its clinical types]
Müslüm Bereketoğlu, Emel Uçak Avşar, Onur Turan, et al.
Tuberkuloz Ve Toraks
|
May 13, 2014
[The changes in smoking related behaviours and second hand smoke after the smoking ban in Izmir]
Pakize Ayşe Turan, Gül Ergör, Onur Turan, et al.
The Clinical Respiratory Journal
|
December 2, 2011
Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT)
Onur Turan, Ozhan Ozdogan, Duygu Gurel, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University
|
August 10, 2017
The contribution of clinical assessments to the diagnostic algorithm of pulmonary embolism
Onur Turan, Deniz Turgut, Turkan Gunay, et al.
European Journal of Clinical Pharmacology
|
February 24, 2024
Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?
Onur Turan, Nalan Ogan, Fulsen Bozkus, et al.
Page
of 4